The funding will enable Posos to continue developing its tool for recommending personalised drug prescriptions based on the patient and the risks identified in their prescriptions, to recruit twenty additional employees, and to deploy its solution internationally.
To complete this transaction, Reed Smith Paris mobilised a multidisciplinary team composed of Guilain Hippolyte (partner) and Marco Hazan (associate) for the Corporate and M&A part; Marianne Schaffner (partner), Thierry Lautier (partner), William Salinger (patent attorney) and Christophe Arfan (associate) for the intellectual property issues; as well as Natasha Tardif (partner) and Camille Martin Saint Leon (associate) for the regulatory aspects.
About Reed Smith
Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. With an inclusive culture and innovative mindset, we deliver smarter, more creative legal services that drive better outcomes for our clients. Our deep industry knowledge, long-standing relationships and collaborative structure make us the go-to partner for complex disputes, transactions and regulatory matters.
For more information, please visit reedsmith.com.